Global Contraceptive Devices Market Size By Type (Male Contraceptive Devices, Female Contraceptive Devices), By Application (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2023...

The Global Contraceptive Devices Market was valued at USD 11.4 billion in 2023 and is projected to reach USD 20.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2023–2031). Rising awareness about family planning, increasing initiatives by governments and NGOs to promote contraceptive use, and growing concerns over unplanned pregnancies are propelling market expansion. Moreover, technological innovations and the introduction of hormone-free and long-acting reversible contraceptives (LARCs) are further supporting growth.

Drivers:

1. Rising Awareness and Education Campaigns:

Efforts by healthcare organizations and governments to promote reproductive health and prevent unplanned pregnancies are increasing awareness about contraceptive methods, thereby driving adoption.

2. Technological Advancements:

Innovative product designs such as smart contraceptive devices, hormone-free options, and non-invasive alternatives are gaining popularity, offering enhanced user convenience and efficacy.

3. Increasing Demand for Long-Acting Reversible Contraceptives (LARCs):

Devices like intrauterine devices (IUDs) and subdermal implants are witnessing higher adoption due to their extended effectiveness and reduced need for frequent medical attention.

Restraints:

1. Social and Cultural Barriers:

In various regions, cultural taboos and religious beliefs restrict open discussions and use of contraceptive devices, hampering market penetration.

2. Adverse Effects and Product Recalls:

Concerns related to side effects, allergic reactions, and historical recalls of certain contraceptive devices can diminish consumer trust and adoption.

Opportunity:

1. Growth Potential in Emerging Economies:

Expanding healthcare infrastructure and rising female literacy in emerging economies such as India, Brazil, and parts of Africa provide significant untapped market potential.

2. E-commerce and Telehealth Channels:

The rising influence of digital health and telemedicine platforms is making contraceptives more accessible, especially for consumers in remote and underserved regions.

Market by System Type Insights:

Based on system type, Intrauterine Devices (IUDs) accounted for the largest market share in 2023. Their long-term efficacy, reversibility, and minimal maintenance have made IUDs a preferred choice. The segment is expected to retain dominance, while barrier methods (such as condoms and diaphragms) continue to grow due to accessibility and over-the-counter availability.

Market by End-use Insights:

In terms of end-use, the Hospital & Clinics segment dominated the market in 2023, supported by the availability of trained professionals and government-subsidized programs. However, the Homecare Settings segment is projected to grow rapidly due to the surge in self-administration of contraceptives, especially barrier and hormonal methods.

Market by Regional Insights:

Geographically, North America led the global contraceptive devices market in 2023, attributed to widespread awareness, strong healthcare infrastructure, and favorable reimbursement policies. Meanwhile, Asia-Pacific is expected to exhibit the fastest growth, driven by government initiatives, increasing access to contraception, and rising healthcare investments.

Competitive Scenario:

Key players in the market include Bayer AG, CooperSurgical Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Reckitt Benckiser Group plc, Church & Dwight Co. Inc., Medisafe Distribution Inc., and Mayer Laboratories Inc. These companies are investing in R&D, expanding product portfolios, and engaging in strategic partnerships to strengthen their market presence.

Recent Developments:

In 2023, Bayer AG introduced an upgraded version of its hormonal IUD with improved patient comfort.

CooperSurgical acquired a regional contraceptive solutions provider in 2024 to expand its footprint in emerging markets.

Merck & Co. launched a mobile app in 2025 for women to track fertility and manage contraceptive device usage, integrating digital health with physical products.

Scope of Work – Global Contraceptive Devices Market

Key Market Developments:

2023: Bayer AG launched a next-gen hormonal IUD with lower hormone doses.

2024: Teva introduced a hormone-free vaginal ring with improved usability.

2025: CooperSurgical invested in AI-based contraception advisory platforms to enhance consumer decision-making.

FAQs:

1) What is the current market size of the Global Contraceptive Devices Market?

The market was valued at USD 11.4 billion in 2023.

2) What is the major growth driver of the Global Contraceptive Devices Market?

Rising awareness about reproductive health and increasing adoption of LARCs are major drivers.

3) Which is the largest region during the forecast period in the Global Contraceptive Devices Market?

North America currently holds the largest market share, while Asia-Pacific is the fastest-growing region.

4) Which segment accounted for the largest market share in the Global Contraceptive Devices Market?

The Intrauterine Devices (IUDs) segment held the largest share in 2023.

5) Who are the key market players in the Global Contraceptive Devices Market?

Major players include Bayer AG, CooperSurgical, Merck & Co., Teva Pharmaceuticals, and Church & Dwight Co. Inc.